A multinational research team called TREATKCNQ is working closely together with patient families and advocacy groups…
tools@teamitresearch.com1 December 2025
This Forbes article highlights iDR25 (the International Drug Repurposing Conference) and the growing potential of drug repurposing to expand treatment possibilities in rare diseases.
REMEDi4ALL features in a New York Times article on the power of AI in drug repurposing with an interview from REMEDi4ALL Scientific Coordinator Donald Lo.
You can unsubscribe at any time.
You can unsubscribe at any time.